Data Foundry

Medical device recalls 2022

Accelerate PhenoTest BC kit REF 10101018 — Class II medical device recall Z-0345-2023

Ongoing recall by Accelerate Diagnostics Inc, reported 2022-12-07, distributed in AR, CA, DC, FL, GA, IA, IL, IN…. Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting

Recall numberZ-0345-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAccelerate Diagnostics Inc, Tucson, AZ, United States
Recall initiated2022-10-17
Classified2022-11-30
Reported by FDA2022-12-07
DistributedAR, CA, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MN, MO, MS, MT, NC, ND, NJ, NY, OH, PA, RI, SC, TN, TX, VA, WA, WV
Countries outside the USAE, DE, ES, IT, KW, LV, PL, PT, RO, SA
Quantity200 kits
Pathogensstaphylococcus
UPC / GTIN / UDI-DI00862011000307
Lot numbers5549A, 5566A, 5588A, 5606A, 5612A
Model numbers10101018

Product

Accelerate PhenoTest BC kit REF 10101018

Reason for recall

Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0345-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.